SABBY 13G HEB 9.01.16

Company

AIM ImmunoTech Inc.

Filed

September 1, 2016

Accession Number

0001535610-16-000162

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →